Case Report: Use of endobronchial Watanabe spigot and coagulation factor XIII supplementation in the treatment of persistent pneumothorax due to pneumocystis pneumonia with human immunodeficiency virus infection
- PMID: 36275806
- PMCID: PMC9579333
- DOI: 10.3389/fmed.2022.956333
Case Report: Use of endobronchial Watanabe spigot and coagulation factor XIII supplementation in the treatment of persistent pneumothorax due to pneumocystis pneumonia with human immunodeficiency virus infection
Abstract
Pneumocystis jiroveceii pneumonia is one of the most common opportunistic infections associated with human immunodeficiency virus. Endobronchial Watanabe spigot has been recommended for refractory pneumothorax, even with persistant air leak despite continuous negative pressure control via thoracic drainage. Moreover, coagulation factor XIII is considered effective in wound healing.
Keywords: blood coagulation factor XIII; endobronchial Watanabe spigot; human immunodeficiency virus; pneumocystis jiroveceii pneumonia; pneumothorax.
Copyright © 2022 Koyama, Minami, Isobe, Shirai, Okimoto and Tomoda.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

References
-
- Matesanz López C, Cardona Arias AF, Río Ramírez MT, Díaz Ibero G, Rodríguez Álvarez SJ, Juretschke Moragues MA. Simultaneous bilateral pneumothorax in an immunocompromised HIV patient with Pneumocystis jirovecii pneumonia. Respir Med Case Rep. (2018) 25:147–9. 10.1016/j.rmcr.2018.08.008 - DOI - PMC - PubMed
-
- King JT Jr, Perkal MF, Rosenthal RA, Gordon AJ, Crystal S, Rodriguez-Barradas MC, et al. . Thirty-day postoperative mortality among individuals with HIV infection receiving antiretroviral therapy and procedure-matched, uninfected comparators. JAMA Surg. (2015) 150:343–51. 10.1001/jamasurg.2014.2257 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources